CHENNAI: Reckitt Benckiser held a Scientific Conference at The Grand Hyatt on September 11, subsequent to the launch of its Power Brand Gaviscon in Tamil Nadu. The conference featured a discussion on ‘Management of Gastroesophageal Reflux Disease (GERD) in the 21st century.’ The workshop was conducted by Dr Robert Heading, President, Association of Gastrointestinal Physiologists and Professor Pali Hungin, Founding member of the UK and the European Society for Primary Care Gastroenterology.Dr KR Palaniswamy, former President - Society for Gastrointestinal Endoscopy of India and Dr Shobna J Bhatia, Professor and Head Department of Gastroenterology, Seth GS Medical College and KEM Hospital, along with Dr Heading and Dr Hungin moderated various informative sessions on the nature and presentation of heartburn in India, management of heartburn and optimising control of reflux that causes heartburn. During the course of the seminar, the delegates also shared their experiences with Indian doctors. Over 200 medical experts from Chennai and Tamil Nadu participated in the workshop.Chander Mohan Sethi, Regional Director – South Asia, Chairman and Managing Director, Reckitt Benckiser (India) Ltd, said, “India is among the most promising markets for health care, growing at an attractive double digit growth rate. We are committed to making a big health care business in India. Gaviscon is the No. 1 brand for heartburn in Europe and is trusted by doctors and consumers alike for its efficacy and quick action. This is yet another step at RB to provide best products to our consumers from our Global Power Brand portfolio," he claims.Gaviscon is a medicine for heartburn which gives relief from symptoms of heartburn and acidity. Heartburn is reflux of acid into the food pipe.
Comments
0 comment